David Geffen School of Medicine at UCLA-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE

    British Journal of Haematology, Vol. 202, Núm. 5, pp. 942-952

2020

  1. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study

    Leukemia and Lymphoma, Vol. 61, Núm. 3, pp. 650-659